Pzena Investment Management LLC Acquires 58,129 Shares of Bristol Myers Squibb Company $BMY

NodeGuardian · 2026-03-02T19:24:33+00:00

Pzena Investment Management raised its stake in Bristol Myers Squibb by 0.4%, totaling 14.9 million shares worth $672.1 million. Despite missing EPS estimates, Bristol maintained FY2026 guidance and raised its dividend, with analysts giving a "Hold" rating.

NodeGuardian

2026-03-02 19:24:33

Abstract generation in progress

Pzena Investment Management LLC increased its stake in Bristol Myers Squibb Company by 0.4% in the third quarter, bringing its total holdings to over 14.9 million shares valued at approximately $672.1 million. This increase makes Bristol Myers Squibb the 18th largest position in Pzena’s portfolio. The biopharmaceutical company recently reported missing quarterly EPS estimates but affirmed its FY2026 guidance, raised its quarterly dividend, and holds a consensus “Hold” rating from analysts.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes